Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
Researchers call on hematologists and pharmacists to make sure life-saving treatment is kept on-hand for patients with rare leukemia.
Cancer patients with lower health literacy reported worse quality of life.
Although most young people survive cancer, secondary effects from the illness and its treatment can increase future health risks.
A unique analysis measures treatment-free survival after immunotherapy in patients with advanced renal cell carcinoma.
Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.
Soheil Meshinchi, MD, PhD, discusses developing personalized therapies for the deadliest childhood leukemia that have fewer side effects.
Research has shown that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of HCC.
Paxlovid dramatically reduced the risk of severe illness and death, but it must be started soon after developing symptoms.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Study findings from the Dana-Farber Cancer Institute arrive as colorectal cancer rates are increasing among younger people.
The revised 2021 recommendations might not dramatically improve access to screening for minorities.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Aerobic and pelvic floor exercises as well as yoga appear to help prostate cancer patients with sexual problems.
Vaccine effectiveness for children ages 5 to 11 was 91%, and serious side effects are rare.
Excess body fat, inflammation and insulin resistance are linked to breast cancer in post-menopausal women. Here’s how to lower the risk.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.